{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:28:34Z","timestamp":1789450114273,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.11.084","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T17:11:14Z","timestamp":1323364274000},"page":"712-721","source":"Crossref","is-referenced-by-count":26,"title":["Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide"],"prefix":"10.1016","volume":"30","author":[{"given":"Wendell D.","family":"Zollinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janiine G.","family":"Babcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Matyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila M.","family":"Wassef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl R.","family":"Alving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.11.084_bib0005","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0010","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0015","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized Phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0020","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0025","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"de Moraes","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0030","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against serogroup B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0035","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB\u2122: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0040","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","article-title":"Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0045","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.vaccine.2006.09.025","article-title":"Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs","volume":"25","author":"van den Dobbelsteen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0220","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1128\/IAI.05125-11","article-title":"Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B. Infection and Immun","volume":"79","author":"Schmiel","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0264-410X(99)00216-9","article-title":"Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers","volume":"18","author":"Drabick","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0060","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1016\/j.vaccine.2010.05.006","article-title":"Design and evaluation in animals of a broadly protective meningococcal group B native outer membrane vesicle vaccine","volume":"28","author":"Zollinger","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0065","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression","volume":"29","author":"Keiser","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0070","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.70.2.702-707.2002","article-title":"Group B intranasal meningococcal native outer membrane vesicle vaccine: immunogenicity and safety testing","volume":"70","author":"Katial","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0075","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1016\/j.vaccine.2010.08.048","article-title":"A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA","volume":"28","author":"Keiser","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0080","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0008-6215(96)00305-9","article-title":"Structural basis of the Neisseria meningitidis immunotypes including the L4 and L7 immunotypes","volume":"298","author":"Kogan","year":"1997","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0090","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1128\/IAI.62.12.5290-5295.1994","article-title":"Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity","volume":"62","author":"Moran","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0095","unstructured":"Zollinger WD, Boslego J, Moran E, Brandt B, Collins H, Mandrell R, et al. Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines. U.S. Patent No. 4,707,543; November 17, 1987."},{"key":"10.1016\/j.vaccine.2011.11.084_bib0100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1515\/znb-1952-0303","article-title":"Uber die Extraktion von bakterien mit Phenol\/Wasser","volume":"7b","author":"Westphal","year":"1952","journal-title":"Z Naturforsch"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/immu.1994.1023","article-title":"Liposomes as carriers for vaccines","volume":"4","author":"Wassef","year":"1994","journal-title":"Immunomethods"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0110","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/CVI.00255-09","article-title":"Characterization of an antibody depletion assay for analysis of bactericidal antibody specificity","volume":"16","author":"Zollinger","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0022-1759(81)90130-7","article-title":"A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies","volume":"46","author":"Zollinger","year":"1981","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/IAI.67.1.113-119.1999","article-title":"Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice","volume":"67","author":"Saunders","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1084\/jem.168.1.107","volume":"168","author":"Mandrell","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0003-2697(78)90260-9","article-title":"A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria","volume":"85","author":"Karkhanis","year":"1978","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0140","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0003-2697(82)90673-X","article-title":"A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels","volume":"119","author":"Tsai","year":"1982","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(91)90120-5","article-title":"Liposomes as carriers of antigens and adjuvants","volume":"140","author":"Alving","year":"1991","journal-title":"J Immunol Meth"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0225","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1073\/pnas.89.1.358","article-title":"Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy","volume":"89","author":"Fries","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0160","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1016\/j.vaccine.2009.08.105","article-title":"Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells memory CD8+ T-cells, and pro-inflammatory cytokines","volume":"27","author":"Steers","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0165","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/infdis\/174.2.361","article-title":"Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes","volume":"174","author":"Heppner","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0170","unstructured":"Pavliak V, Fortuna-Nevin M, Monteiro M, Mason K, Zhu D. Neisseria meningitidis LOS conjugate vaccine against meningococcal disease. In: Abstr 14th international pathogenic neisseria conference. Milwaukee, WI; 2004. p. 8 [Abstr]."},{"key":"10.1016\/j.vaccine.2011.11.084_bib0175","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1016\/j.vaccine.2005.06.011","article-title":"Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits","volume":"23","author":"Cox","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0180","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1128\/IAI.60.9.3897-3903.1992","article-title":"Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes","volume":"60","author":"Petrov","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0185","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/IAI.61.6.2390-2395.1993","article-title":"Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models","volume":"61","author":"Orr","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-1759(90)90262-T","article-title":"Preparation of proteosome-based vaccines. Correlation of immunogenicity with physical characteristics","volume":"135","author":"Ruegg","year":"1990","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0195","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0264-410X(95)00101-6","article-title":"The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis","volume":"13","author":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0200","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1099\/00221287-144-11-3027","article-title":"Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci","volume":"144","author":"Christodoulides","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vaccine.2005.07.056","article-title":"Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis","volume":"24","author":"Humphries","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0210","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/IAI.69.6.3809-3816.2001","article-title":"Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci","volume":"69","author":"Jolley","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.11.084_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(84)90080-2","article-title":"Use of a zwitterionic detergent for the restoration of the antibody-binding capacity of electroblotted meningococcal outer membrane proteins","volume":"67","author":"Mandrell","year":"1984","journal-title":"J Immunol Methods"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11018809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11018809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T12:08:42Z","timestamp":1639915722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11018809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X11018809"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}